Patients seek reassurances after IVF mix ups
Known as electronic witnessing, the mechanism prevents tissue mix ups and involves multiple layers of identity-document checks by humans and computers.
While rarely needed, it's a safeguard standard that's becoming the norm in an industry suddenly needing to win back public trust following revelations of two devastating errors at one of Australia's biggest facilities.
The first saw a mother give birth to another couple's biological child after she was impregnated with the wrong embryo at Monash IVF in Brisbane some years ago.
The other involved a woman incorrectly receiving her own embryo instead of one from her same-sex partner as requested, which happened at the company's Melbourne clinic earlier in June.
The bungles have sparked a rush of patients reaching out to fertility clinics seeking reassurances about their own sperm, eggs, embryos and children.
"At the moment, the trust in the industry has been eroded," says Connect IVF scientific director Lauren Hiser.
"It certainly opened up the conversation again.
"I do believe those questions inherently are always there but it's probably made patients verbalise it a little."
She's found explaining electronic and human witnessing practices at her own facility in Sydney have put patients' minds at ease but knows it will take time for confidence to return.
Monash IVF has repeatedly apologised and vowed to introduce additional verification processes over and above normal practices.
Official probes into what happened are under way, with the company yet to offer explanations for how the mix ups occurred beyond two ASX announcements.
Pink Elephants Support Network chief operating officer Jen Tupaea is among many Monash IVF patients wanting to know more.
She's noticed a general sense of uneasiness set in among IVF parents across Australia and believes patients need more reassurances that all due diligence is done.
"There's already a lot of uncertainty and worry and sort of lack of control and I think this just adds another element to that," Ms Tupaea says.
'Patchwork' is a term often used to describe the 40-odd pieces of legislation affecting IVF in Australian states and territories.
There's variations on anything from how long embryos can be stored to how many families can use the same sperm donor and even certain states banning overseas donor eggs.
Until now, the industry has largely been left to regulate itself through yearly accreditations but the mix ups spurred health ministers including Victoria's Mary-Anne Thomas to unite behind a push to explore national regulation.
It's something Pink Elephants supports, with Ms Tupaea describing IVF regulation as "a bit of a black box".
She's aware of parents worried about what would happen if a similar devastating mix up occurred at a smaller clinic that doesn't have ASX reporting requirements.
"The main concern when something like that comes up is, why are we hearing about it now, and what are we not hearing about?" she says.
Australia's first IVF baby was born 45 years ago and now some 20,000 babies conceived through IVF are born here each year.
Greater regulation is also something clinicians want, Ms Hiser explains.
"We regulated ourselves because no one enforced it upon us and because we saw the need for patient safety," she says.
"We've done a very good job of that up until now, and that's why I'm very curious to find out exactly what went wrong (at Monash IVF) because we're having a hard time ... understanding how it did happen."
IVF researcher and University of Melbourne Senior Research Fellow Sarah Lensen wants any future regulation to also include greater monitoring of 'add-on' treatments.
She specialises in evaluating their safety and effectiveness, saying for the most part there isn't a lot of good evidence they help patients.
"The banking industry is highly regulated and I think for the better, so I don't know why we wouldn't accept independent regulation in this space," Dr Lensen says.
City Fertility Group's Victorian Scientific Director Jayne Mullen wants patients to have confidence regardless of how big a clinic is, professionals are bound by strict accreditation and licensing requirements so any mistakes must be reported to health authorities.
"We're continuously monitored and audited, we are obliged to report any serious adverse event," she says.
The scientist is also fielding more calls than usual from concerned parents, offering to take them through laboratories.
While fully confident in their use of electronic witnessing and human verification, she says the Monash IVF mix ups still cause her to pause and review protocols.
"Doctors, nurses, scientists, everyone that's working in our IVF industry, we have the best of intentions, we want everyone to walk away with a happy, healthy baby," she says.
"Mistakes are so rare."
Both Ms Mullen and Ms Hiser find explaining safety controls has put many patients at ease, urging anyone still feeling nervous about treatments to reach out to their providers.
"If they don't, say, have an electronic witnessing system in place ask them why don't you, why do my fees not cover you having this extra layer of security?" Ms Hiser says.
"If you don't have that, fine, that's okay but tell me how you control (safety).
"If you still have questions after that, then maybe ask yourself are they the people that I want to be doing my IVF journey with?"
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
7NEWS
10 minutes ago
- 7NEWS
Albanese government pushes forward with prescription medicine cap at $25
Medicines listed on the Pharmaceutical Benefits Scheme (PBS) will be capped at $25 per prescription from the start of 2026, down from the current $31.60, with the Albanese government to introduce laws confirming the changes this week. The major federal election promise will also see the price of PBS scripts frozen at its current level of $7.70 for pensioners until 2030. The changes will cost taxpayers $200 million per year, but are likely to be popular with voters. The Coalition matched the policy during the election and is likely to see the bill pass through parliament relatively quickly. However, Labor used the policy during the federal campaign in April and May to run a scare campaign accusing Peter Dutton and the Opposition of being 'Trump-Lite' and wanting a US style health system. The Prime Minister, Anthony Albanese, says: 'The size of your bank balance shouldn't determine the quality of your healthcare'. 'We said we would make cheaper medicines even cheaper - that is exactly what we are doing,' Albanese said. 'This is another example of cost of living relief that helps every Australian. The Health Minister, Mark Butler, says the last time PBS medicines cost no more than $25 was 2004 – more than 20 years ago. 'The Albanese Government has been focused on delivering cheaper medicines for Australians,' Butler said. 'Cheaper medicines are good for the hip pocket and good for your health.' The Albanese Government has started the first two sitting weeks of its second term trying to keep the focus on its election promises. Last week it introduced bills to cut HECS debt by 20 percent, entrench penalty rates in workplace agreements, and safety reforms for the childcare sector.
West Australian
40 minutes ago
- West Australian
Australia called to lift on global health as US yields
Australia must come to the party with more money to combat climate-related health issues, antimicrobial resistance and future pandemics. That's the bottom line of research that indicates the well-off nation is not pulling enough weight on the world stage to understand, anticipate and respond to emerging international health threats. The Australian government spent just under $630 billion on health between 2017 and 2023, according to a report commissioned by the Australian Global Health Alliance. About $35 billion was directed to health and medical research but just $2 billion was specifically set aside for global research. The country must increase and realign its funding to address and anticipate global health challenges more effectively, the report said. "Despite commendable efforts, Australia's investment in global health research lags behind its international peers," it said. "Key areas such as the impact of climate change on health, antimicrobial resistance, and pandemic preparedness are notably underfunded." Alliance executive director Selina Namchee Lo said the global scientific community was successful in rapidly delivering vaccines and treatments during the COVID-19 pandemic. But where it fell short was equity, with some of the hardest-hit countries missing out. "What we're saying is equity is not optional for global health," Dr Lo told AAP. Another report, also commissioned by the alliance with Pacific Friends of Global Health, detailed the impact of two Australian-backed global public private partnerships in the Indo-Pacific. Australia has collectively poured more than $2.5 billion into The Global Fund and Gavi since 2000, helping to immunise more than 100 million children and save lives in the region. But the country's level of foreign aid has been been in "significant decline" since 2012, stagnating at $US3 billion annually over the past seven years. The multilateral aid landscape is "under pressure" after the US and UK reduced their commitments, the report said. It comes after US President Donald Trump's administration dismantled the US Agency for International Development, cutting funding to its aid programs worldwide. Dr Lo, who has nearly three decades experience in global and international health, said the abrupt exit of USAID left communities "in the lurch". "It's never good to have one group, whether it's a philanthropist or a country, be a monopoly," she said. "Because when they pull out, this is what happens." The Indo-Pacific still accounts for 25 per cent of global infections, with 6.7 million people in the region living with HIV and malaria rampant in Papua New Guinea. Pacific Friends of Global Health chair Brendan Crabb wants Australia to take up the mantle. "As the US administration dramatically steps back from global health leadership, Australia has a critical opportunity to convene and partner with Asia Pacific countries to advance the health priorities of the region," the Burnet Institute chief executive said.
Perth Now
40 minutes ago
- Perth Now
Australia called to lift on global health as US yields
Australia must come to the party with more money to combat climate-related health issues, antimicrobial resistance and future pandemics. That's the bottom line of research that indicates the well-off nation is not pulling enough weight on the world stage to understand, anticipate and respond to emerging international health threats. The Australian government spent just under $630 billion on health between 2017 and 2023, according to a report commissioned by the Australian Global Health Alliance. About $35 billion was directed to health and medical research but just $2 billion was specifically set aside for global research. The country must increase and realign its funding to address and anticipate global health challenges more effectively, the report said. "Despite commendable efforts, Australia's investment in global health research lags behind its international peers," it said. "Key areas such as the impact of climate change on health, antimicrobial resistance, and pandemic preparedness are notably underfunded." Alliance executive director Selina Namchee Lo said the global scientific community was successful in rapidly delivering vaccines and treatments during the COVID-19 pandemic. But where it fell short was equity, with some of the hardest-hit countries missing out. "What we're saying is equity is not optional for global health," Dr Lo told AAP. Another report, also commissioned by the alliance with Pacific Friends of Global Health, detailed the impact of two Australian-backed global public private partnerships in the Indo-Pacific. Australia has collectively poured more than $2.5 billion into The Global Fund and Gavi since 2000, helping to immunise more than 100 million children and save lives in the region. But the country's level of foreign aid has been been in "significant decline" since 2012, stagnating at $US3 billion annually over the past seven years. The multilateral aid landscape is "under pressure" after the US and UK reduced their commitments, the report said. It comes after US President Donald Trump's administration dismantled the US Agency for International Development, cutting funding to its aid programs worldwide. Dr Lo, who has nearly three decades experience in global and international health, said the abrupt exit of USAID left communities "in the lurch". "It's never good to have one group, whether it's a philanthropist or a country, be a monopoly," she said. "Because when they pull out, this is what happens." The Indo-Pacific still accounts for 25 per cent of global infections, with 6.7 million people in the region living with HIV and malaria rampant in Papua New Guinea. Pacific Friends of Global Health chair Brendan Crabb wants Australia to take up the mantle. "As the US administration dramatically steps back from global health leadership, Australia has a critical opportunity to convene and partner with Asia Pacific countries to advance the health priorities of the region," the Burnet Institute chief executive said.
